CLINICAL ISSUES

The conundrum of antithrombotic drugs before, during and after primary PCI

EuroIntervention 2014;10-T64-T73. DOI: 10.4244/EIJV10STA11

Bernardo Cortese1, MD; Rodrigo Sebik1, MD; Marco Valgimigli2*, MD, PhD

1. Interventional Cardiology, A.O. Fatebenefratelli, Milan, Italy; 2. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands

Primary percutaneous coronary intervention (PPCI) has dramatically changed the scenario of ST-segment elevation myocardial infarction, consistently decreasing mortality and morbidity. These goals have been reached thanks to m

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bivalirudindirect thrombin inhibitorglycoprotein iib/iiia inhibitorsp2y<span class="indice">12</span> inhibitorsprimary percutaneous coronary intervention

Share on Facebook Share on Twitter Share on Linkedin